Abstract | OBJECTIVE: METHODS: Three groups of C57BL6/J mice underwent chemical and mechanical denudation of corneal and limbal epithelium. One group remained tumor free while the other 2 were implanted with LLC cells (either the HM or LM clones) subcutaneously the day before, 2 weeks after, or 4 weeks after denudation. Corneas were harvested 2 weeks after tumor implantation (at 2, 4, and 6 weeks after denudation for tumor-free mice). Neovascularization was quantified by CD31 immunostaining. In a second experiment, recombinant angiostatin was delivered continuously for 2 weeks via an osmotic pump in mice with established corneal neovascularization. RESULTS: The mean percentages of neovascularized corneal area in mice 2 weeks after LM-LLC implantation were 4.6%, 3.7%, and 37.0%, at 2, 4, and 6 weeks after scraping, respectively. In contrast, in the mice implanted with HM-LLC, the corresponding values were 45.4% (P =.01), 90.1% (P =.03), and 80.3% (P =.005). For tumor-free mice, the corresponding values were 62.0% (P =.003), 68.9% (P =.03), and 59.3% (P =.06). Mice implanted with angiostatin pumps had a 37.7% neovascularized corneal area 2 weeks after implantation and 4 weeks after scraping while mice implanted with sham pumps had 60.5% (P =.007). CONCLUSION: CLINICAL RELEVANCE: This appears to be the first evidence of biologically induced regression of corneal neovascularization, and the first direct demonstration of angiostatin-induced regression of neovascularization in any tissue.
|
Authors | Balamurali K Ambati, Antonia M Joussen, Jayakrishna Ambati, Yasufumi Moromizato, Chandan Guha, Kashi Javaherian, Stephen Gillies, Michael S O'Reilly, Anthony P Adamis |
Journal | Archives of ophthalmology (Chicago, Ill. : 1960)
(Arch Ophthalmol)
Vol. 120
Issue 8
Pg. 1063-8
(Aug 2002)
ISSN: 0003-9950 [Print] United States |
PMID | 12149060
(Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Angiogenesis Inhibitors
- Peptide Fragments
- Platelet Endothelial Cell Adhesion Molecule-1
- Recombinant Proteins
- Angiostatins
- Plasminogen
|
Topics |
- Angiogenesis Inhibitors
(metabolism, therapeutic use)
- Angiostatins
- Animals
- Carcinoma, Lewis Lung
(metabolism)
- Cornea
(blood supply, drug effects, pathology)
- Corneal Neovascularization
(drug therapy, metabolism, pathology)
- Fluorophotometry
- Infusion Pumps, Implantable
- Lung Neoplasms
(metabolism)
- Male
- Mice
- Mice, Inbred C57BL
- Neoplasm Transplantation
- Peptide Fragments
(metabolism, therapeutic use)
- Plasminogen
(metabolism, therapeutic use)
- Platelet Endothelial Cell Adhesion Molecule-1
(metabolism)
- Recombinant Proteins
|